|
2005 Physicians' Desk Reference with PDR Electronic Library on CD-Rom
The Authoritative Source of FDA-Approved Information on Prescription
Drugs.
Physicians have turned to PDR� for the latest word on
prescription drugs for 59 years! Today, PDR
is considered the standard
prescription drug reference and can be found in virtually every
physician's office, hospital and pharmacy in the United States. In fact,
nine out of ten doctors consider PDR their most important reference
source. The 59th edition is more than 3,000 pages�our most
comprehensive edition ever!
These critical new drugs are included in the 2005 edition:
Cialis (tadalafil), a new selective inhibitor of cyclic guanosine
monophosphate-specific phosphodiesterase type 5 indicated for the
treatment of erectile dysfunction.
Crestor (rosuvastatin calcium), a new HMG-CoA reductase inhibitor
indicated as an adjunct to diet in the treatment of primary
hypercholesterolemia, mixed dyslipidemia, and elevated triglyceride
levels, or as an adjunct to other lipid-lowering therapies (or if these
are unavailable) for treatment of homozygous familial
hypercholesterolemia.
Levitra (vardenafil HCl), a new selective inhibitor of cyclic
guanosine monophosphate-specific phosphodiesterase type 5 indicated for
the treatment of erectile dysfunction.
Lexiva (fosamprenavir calcium), a new protease inhibitor indicated
in combination with other antiretroviral agents for the treatment of HIV
infection in adults.
Namenda (memantine HCl), the first NMDA receptor antagonist
indicated for the treatment of moderate to severe dementia of the
Alzheimer's type.
Raptiva (efalizumab), a new recombinant humanized IgG1 kappa
isotype monoclonal antibody indicated for the treatment of adults with
chronic moderate to severe plaque psoriasis who are candidates for
systemic therapy or phototherapy.
Symbyax (olanzapine and fluoxetine HCI), a new combination of 2
psychotropic agents for the treatment of depressive episodes associated
with bipolar disorder.
You'll find the most complete data on over 4,000 drugs by brand
and generic name (both in the same convenient index), manufacturer, and
product category. Your 2005 PDR provides usage information and warnings,
drug interactions, plus more than 2,000 full-size, full-color photos
cross-referenced to the product information.
You will also find:
>Phonetic spelling for most listings
>A key to controlled substances
>FDA use-in-pregnancy ratings
>Contraindications
>All other FDA-required information
>Clinical pharmacology
>Adverse reactions
>Pediatric use
>Dosages
On average, over 70% of the drugs found in PDR have prescribing
information that has been updated from that found in the previous years'
edition. This means that each year thousands of changes are made to
drugs. Among these changes are:
>Interactions with other drugs
>Side Effects
>Recommended Dosages
>Contraindications
>Black box warnings
>How supplied methods...
Email a friend this page.
|
